520 related articles for article (PubMed ID: 11578292)
1. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation.
Morris CD; Byrne JP; Armstrong GR; Attwood SE
Br J Surg; 2001 Oct; 88(10):1357-62. PubMed ID: 11578292
[TBL] [Abstract][Full Text] [Related]
2. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
Jankowski JA; Anderson M
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
[TBL] [Abstract][Full Text] [Related]
4. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus.
Attwood SE; Lewis CJ; Caplin S; Hemming K; Armstrong G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):258-63. PubMed ID: 15017666
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation.
Kelty CJ; Ackroyd R; Brown NJ; Stephenson TJ; Stoddard CJ; Reed MW
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1289-96. PubMed ID: 15606390
[TBL] [Abstract][Full Text] [Related]
6. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of Barrett's oesophagus. A general survey.
Petrakis IE; Sciacca V; Iascone C
Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
[TBL] [Abstract][Full Text] [Related]
8. Molecular evaluation of ablative therapy of Barrett's oesophagus.
Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H
J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364
[TBL] [Abstract][Full Text] [Related]
9. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
10. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation.
Byrne JP; Armstrong GR; Attwood SE
Am J Gastroenterol; 1998 Oct; 93(10):1810-5. PubMed ID: 9772036
[TBL] [Abstract][Full Text] [Related]
11. A surveillance programme for Barrett's oesophagus in a UK general hospital.
Olithselvan A; Gorard DA; McIntyre AS
Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
[TBL] [Abstract][Full Text] [Related]
12. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
13. [Barrett's oesophagus: place of antireflux surgery].
Mabrut JY; Baulieux J
Ann Chir; 2006 Mar; 131(3):177-82. PubMed ID: 16527242
[TBL] [Abstract][Full Text] [Related]
14. Barrett's oesophagus: long-term follow-up after complete ablation with argon plasma coagulation and the factors that determine its recurrence.
Ferraris R; Fracchia M; Foti M; Sidoli L; Taraglio S; Vigano' L; Giaccone C; Rebecchi F; Meineri G; Senore C; Pera A;
Aliment Pharmacol Ther; 2007 Apr; 25(7):835-40. PubMed ID: 17373922
[TBL] [Abstract][Full Text] [Related]
15. [Revision needed of follow-up policy for Barrett's esophagus].
Giard RW; Coebergh JW; Ouwendijk RJ
Ned Tijdschr Geneeskd; 2002 Jan; 146(4):150-4. PubMed ID: 11845562
[TBL] [Abstract][Full Text] [Related]
16. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus.
Pech O; Behrens A; May A; Nachbar L; Gossner L; Rabenstein T; Manner H; Guenter E; Huijsmans J; Vieth M; Stolte M; Ell C
Gut; 2008 Sep; 57(9):1200-6. PubMed ID: 18460553
[TBL] [Abstract][Full Text] [Related]
17. High power setting argon plasma coagulation for the eradication of Barrett's esophagus.
Pereira-Lima JC; Busnello JV; Saul C; Toneloto EB; Lopes CV; Rynkowski CB; Blaya C
Am J Gastroenterol; 2000 Jul; 95(7):1661-8. PubMed ID: 10925965
[TBL] [Abstract][Full Text] [Related]
18. Barrett's oesophagus: the new endoscopic modalities have a future.
Deviere J
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i33-7. PubMed ID: 15711006
[TBL] [Abstract][Full Text] [Related]
19. Ablation of Barrett's oesophagus: towards improved outcomes for oesophageal cancer?
Mayne GC; Bright T; Hussey DJ; Watson DI
ANZ J Surg; 2012 Sep; 82(9):592-8. PubMed ID: 22901306
[TBL] [Abstract][Full Text] [Related]
20. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
Armstrong D
Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]